Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AIV6
Term | Name | Level | Count |
---|---|---|---|
GO:0006040 | amino sugar metabolic process | 4 | 1 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 4 | 1 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009225 | nucleotide-sugar metabolic process | 4 | 1 |
GO:0009226 | nucleotide-sugar biosynthetic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0046349 | amino sugar biosynthetic process | 5 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity | 6 | 8 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0070569 | uridylyltransferase activity | 5 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 287 | 293 | PF00089 | 0.265 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.232 |
CLV_NRD_NRD_1 | 387 | 389 | PF00675 | 0.253 |
CLV_NRD_NRD_1 | 536 | 538 | PF00675 | 0.363 |
CLV_PCSK_KEX2_1 | 536 | 538 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.223 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.232 |
CLV_PCSK_SKI1_1 | 353 | 357 | PF00082 | 0.152 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 412 | 416 | PF00082 | 0.253 |
CLV_PCSK_SKI1_1 | 537 | 541 | PF00082 | 0.485 |
DEG_APCC_DBOX_1 | 179 | 187 | PF00400 | 0.375 |
DEG_APCC_DBOX_1 | 53 | 61 | PF00400 | 0.490 |
DEG_SPOP_SBC_1 | 186 | 190 | PF00917 | 0.434 |
DOC_CDC14_PxL_1 | 89 | 97 | PF14671 | 0.513 |
DOC_MAPK_gen_1 | 274 | 284 | PF00069 | 0.513 |
DOC_MAPK_MEF2A_6 | 180 | 187 | PF00069 | 0.479 |
DOC_MAPK_NFAT4_5 | 180 | 188 | PF00069 | 0.465 |
DOC_PP1_RVXF_1 | 351 | 357 | PF00149 | 0.431 |
DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.410 |
DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.318 |
DOC_USP7_MATH_1 | 259 | 263 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.439 |
DOC_USP7_MATH_1 | 341 | 345 | PF00917 | 0.384 |
DOC_USP7_MATH_1 | 481 | 485 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 518 | 522 | PF00917 | 0.332 |
DOC_USP7_MATH_1 | 539 | 543 | PF00917 | 0.476 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.600 |
DOC_USP7_UBL2_3 | 310 | 314 | PF12436 | 0.410 |
DOC_WW_Pin1_4 | 454 | 459 | PF00397 | 0.500 |
DOC_WW_Pin1_4 | 514 | 519 | PF00397 | 0.334 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.513 |
LIG_14-3-3_CanoR_1 | 500 | 507 | PF00244 | 0.490 |
LIG_14-3-3_CanoR_1 | 536 | 544 | PF00244 | 0.362 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.361 |
LIG_BRCT_BRCA1_1 | 366 | 370 | PF00533 | 0.427 |
LIG_BRCT_BRCA1_1 | 440 | 444 | PF00533 | 0.448 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.465 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.427 |
LIG_FHA_1 | 316 | 322 | PF00498 | 0.482 |
LIG_FHA_1 | 349 | 355 | PF00498 | 0.435 |
LIG_FHA_1 | 468 | 474 | PF00498 | 0.352 |
LIG_FHA_1 | 499 | 505 | PF00498 | 0.474 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.514 |
LIG_FHA_2 | 481 | 487 | PF00498 | 0.539 |
LIG_FHA_2 | 494 | 500 | PF00498 | 0.505 |
LIG_LIR_Gen_1 | 21 | 28 | PF02991 | 0.467 |
LIG_LIR_Gen_1 | 328 | 339 | PF02991 | 0.437 |
LIG_LIR_Gen_1 | 367 | 378 | PF02991 | 0.435 |
LIG_LIR_LC3C_4 | 182 | 187 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 203 | 209 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 21 | 26 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 293 | 299 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 328 | 334 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 335 | 339 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 367 | 373 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 441 | 447 | PF02991 | 0.417 |
LIG_REV1ctd_RIR_1 | 198 | 206 | PF16727 | 0.425 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.439 |
LIG_SH2_GRB2like | 41 | 44 | PF00017 | 0.415 |
LIG_SH2_NCK_1 | 225 | 229 | PF00017 | 0.465 |
LIG_SH2_NCK_1 | 336 | 340 | PF00017 | 0.410 |
LIG_SH2_NCK_1 | 41 | 45 | PF00017 | 0.508 |
LIG_SH2_PTP2 | 278 | 281 | PF00017 | 0.414 |
LIG_SH2_SRC | 225 | 228 | PF00017 | 0.513 |
LIG_SH2_STAP1 | 251 | 255 | PF00017 | 0.520 |
LIG_SH2_STAP1 | 413 | 417 | PF00017 | 0.465 |
LIG_SH2_STAT3 | 155 | 158 | PF00017 | 0.465 |
LIG_SH2_STAT3 | 495 | 498 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 278 | 281 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 336 | 339 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 495 | 498 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 530 | 533 | PF00017 | 0.419 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.456 |
LIG_SH3_3 | 288 | 294 | PF00018 | 0.479 |
LIG_SUMO_SIM_par_1 | 182 | 190 | PF11976 | 0.458 |
LIG_SUMO_SIM_par_1 | 280 | 285 | PF11976 | 0.513 |
LIG_SUMO_SIM_par_1 | 464 | 470 | PF11976 | 0.395 |
LIG_TRAF2_1 | 14 | 17 | PF00917 | 0.436 |
LIG_TRAF2_1 | 29 | 32 | PF00917 | 0.441 |
LIG_TRAF2_1 | 483 | 486 | PF00917 | 0.531 |
LIG_TRAF2_1 | 496 | 499 | PF00917 | 0.525 |
LIG_TYR_ITIM | 276 | 281 | PF00017 | 0.414 |
LIG_TYR_ITIM | 334 | 339 | PF00017 | 0.410 |
LIG_UBA3_1 | 464 | 471 | PF00899 | 0.321 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.513 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.557 |
MOD_CK1_1 | 344 | 350 | PF00069 | 0.419 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.436 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.380 |
MOD_CK2_1 | 313 | 319 | PF00069 | 0.463 |
MOD_CK2_1 | 329 | 335 | PF00069 | 0.374 |
MOD_CK2_1 | 416 | 422 | PF00069 | 0.465 |
MOD_CK2_1 | 480 | 486 | PF00069 | 0.569 |
MOD_CK2_1 | 493 | 499 | PF00069 | 0.431 |
MOD_CK2_1 | 509 | 515 | PF00069 | 0.408 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.195 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.427 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.118 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.180 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.286 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.457 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.278 |
MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.302 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.306 |
MOD_GlcNHglycan | 459 | 462 | PF01048 | 0.498 |
MOD_GlcNHglycan | 491 | 494 | PF01048 | 0.561 |
MOD_GlcNHglycan | 537 | 540 | PF01048 | 0.487 |
MOD_GlcNHglycan | 541 | 544 | PF01048 | 0.492 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.526 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.501 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.545 |
MOD_GSK3_1 | 344 | 351 | PF00069 | 0.494 |
MOD_GSK3_1 | 360 | 367 | PF00069 | 0.406 |
MOD_GSK3_1 | 481 | 488 | PF00069 | 0.510 |
MOD_GSK3_1 | 489 | 496 | PF00069 | 0.589 |
MOD_GSK3_1 | 514 | 521 | PF00069 | 0.335 |
MOD_GSK3_1 | 535 | 542 | PF00069 | 0.505 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.411 |
MOD_N-GLC_1 | 438 | 443 | PF02516 | 0.191 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.431 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.463 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.463 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.424 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.415 |
MOD_NEK2_1 | 378 | 383 | PF00069 | 0.505 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.541 |
MOD_NEK2_1 | 491 | 496 | PF00069 | 0.353 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.301 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.436 |
MOD_PIKK_1 | 194 | 200 | PF00454 | 0.381 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.552 |
MOD_PKA_2 | 387 | 393 | PF00069 | 0.465 |
MOD_PKA_2 | 499 | 505 | PF00069 | 0.495 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.402 |
MOD_PKA_2 | 535 | 541 | PF00069 | 0.442 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.475 |
MOD_Plk_1 | 329 | 335 | PF00069 | 0.352 |
MOD_Plk_1 | 378 | 384 | PF00069 | 0.558 |
MOD_Plk_1 | 438 | 444 | PF00069 | 0.465 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.378 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.435 |
MOD_Plk_4 | 379 | 385 | PF00069 | 0.498 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.424 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.477 |
MOD_ProDKin_1 | 454 | 460 | PF00069 | 0.496 |
MOD_ProDKin_1 | 514 | 520 | PF00069 | 0.336 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.513 |
MOD_SUMO_for_1 | 401 | 404 | PF00179 | 0.410 |
TRG_DiLeu_BaEn_1 | 118 | 123 | PF01217 | 0.513 |
TRG_DiLeu_BaEn_1 | 142 | 147 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 336 | 339 | PF00928 | 0.417 |
TRG_ER_diArg_1 | 237 | 240 | PF00400 | 0.431 |
TRG_ER_diArg_1 | 535 | 537 | PF00400 | 0.306 |
TRG_Pf-PMV_PEXEL_1 | 231 | 235 | PF00026 | 0.210 |
TRG_Pf-PMV_PEXEL_1 | 68 | 73 | PF00026 | 0.421 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PG62 | Leptomonas seymouri | 61% | 98% |
A0A0S4IVW9 | Bodo saltans | 39% | 100% |
A0A1X0P444 | Trypanosomatidae | 45% | 100% |
A0A3S7X721 | Leishmania donovani | 80% | 96% |
A0A422P028 | Trypanosoma rangeli | 40% | 100% |
D0A658 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AHS0 | Leishmania infantum | 80% | 96% |
E9B491 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 98% |
O64765 | Arabidopsis thaliana | 34% | 100% |
O74933 | Candida albicans | 31% | 100% |
O94617 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 100% |
P43123 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
Q16222 | Homo sapiens | 32% | 100% |
Q18493 | Caenorhabditis elegans | 29% | 100% |
Q28CH3 | Xenopus tropicalis | 32% | 100% |
Q3KQV9 | Homo sapiens | 35% | 100% |
Q3TW96 | Mus musculus | 34% | 100% |
Q49ZB5 | Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) | 27% | 100% |
Q4L846 | Staphylococcus haemolyticus (strain JCSC1435) | 28% | 100% |
Q4Q3T5 | Leishmania major | 79% | 100% |
Q54GN5 | Dictyostelium discoideum | 31% | 100% |
Q7ZWD4 | Danio rerio | 32% | 100% |
Q91YN5 | Mus musculus | 33% | 100% |
Q940S3 | Arabidopsis thaliana | 33% | 100% |
V5BYI4 | Trypanosoma cruzi | 43% | 92% |